These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35006008)
1. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Gambacciani M; Fidecicchi T Climacteric; 2022 Apr; 25(2):208-211. PubMed ID: 35006008 [TBL] [Abstract][Full Text] [Related]
2. Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors. Fidecicchi T; Gaspar A; Gambacciani M Menopause; 2023 Feb; 30(2):174-178. PubMed ID: 36696641 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause. Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235 [TBL] [Abstract][Full Text] [Related]
5. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Gambacciani M; Levancini M Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079 [TBL] [Abstract][Full Text] [Related]
6. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Gambacciani M; Levancini M; Cervigni M Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987 [TBL] [Abstract][Full Text] [Related]
7. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Gambacciani M; Levancini M Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800 [TBL] [Abstract][Full Text] [Related]
8. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]
10. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563 [TBL] [Abstract][Full Text] [Related]
11. Short-term results of the combined application of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of periodontal disease: a randomized controlled trial. Laky M; Müller M; Laky B; Arslan M; Wehner C; Husejnagic S; Lettner S; Moritz A; Rausch-Fan X Clin Oral Investig; 2021 Nov; 25(11):6119-6126. PubMed ID: 33813638 [TBL] [Abstract][Full Text] [Related]
12. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study. Gambacciani M; Albertin E; Torelli MG; Bracco GL; Casagrande AC; Martella L; Baiocchi G; Alfieri S; Russo N; Cervigni M; Climacteric; 2020; 23(sup1):S24-S27. PubMed ID: 33124454 [TBL] [Abstract][Full Text] [Related]
13. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM). Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Gaspar A; Brandi H; Gomez V; Luque D Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Combination Therapy With Vaginal and Urethral Erbium-Doped Yttrium-Aluminum-Garnet (Er:YAG) Laser for Overactive Bladder With Urinary Incontinence. Okui N; Okui MA Cureus; 2024 Jun; 16(6):e62363. PubMed ID: 39006699 [TBL] [Abstract][Full Text] [Related]
16. Ablative fractionated erbium:YAG laser for the treatment of ice pick alar scars due to neodymium:YAG laser burns. Cohen JL; Babcock MJ J Drugs Dermatol; 2009 Jan; 8(1):65-7. PubMed ID: 19180898 [TBL] [Abstract][Full Text] [Related]
17. Comparison of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) 1064-nm picosecond laser and fractional 1550-nm erbium fiber laser in facial acne scar treatment. Chayavichitsilp P; Limtong P; Triyangkulsri K; Pratumchart N Lasers Med Sci; 2020 Apr; 35(3):695-700. PubMed ID: 31646393 [TBL] [Abstract][Full Text] [Related]
18. Erbium:yttrium aluminum garnet laser versus Q-switched neodymium:yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum. Balevi A; Ustuner P; Ozdemir M J Cosmet Laser Ther; 2017 Apr; 19(2):100-105. PubMed ID: 27849400 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy alone and in combination with erbium:YAG laser therapy: tracing and objective measurement of melanin index in macular amyloidosis. Nilforoushzadeh MA; Zolghadr S; Heidari-Kharaji M; Alavi S; Mahmoudbeyk M Lasers Med Sci; 2020 Jul; 35(5):1171-1177. PubMed ID: 31916020 [TBL] [Abstract][Full Text] [Related]
20. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]